<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">During February–March, rates of testing fell by 81–90% and new medication therapy by 52–60% (
 <italic>P</italic> &lt; 0.001 for all before and after comparisons using a 
 <italic>t</italic> test). The rates started a modest rebound in early April, more pronounced at site 2 (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>).
</p>
